|
SciENcv support for federal research grant applications
|
Resource Development
|
Not Reported
|
NLM, OD/OER, OD/OM/ORF
|
Science Experts Network Curriculum Vitae (SciENcv) is a free online service that helps grant applicants create biosketch profiles required for application packages. This NLM service supports NIH, the National Science Foundation (NSF), and DOEd biosketch formats and reduces administrative burden by leveraging existing data that a researcher may already have in an external data source such as eRA Commons or ORCiD. In 2019, NLM and NSF entered into a new interagency agreement to extend this support to include the Current and Pending Support documentation that is part of the NSF grant application package. New NSF forms were deployed in May 2024 to support NSF PAPPG 24-1 and were the first example of the federal common application formats in active use. Additional agencies are expected to join the system in the coming year. https://www.ncbi.nlm.nih.gov/sciencv/
|
|
Scientific Registry of Transplant Recipients (SRTR) Visiting Committee
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NIAID
|
The SRTR Visiting Committee advises the SRTR on:(1) analytic methodologies to support the Organ Procurement and Transplantation Network policy development and evaluation; (2) objectives, study designs, and statistical methods for research projects performed by SRTR, including risk-adjusted analyses of organ procurement organization and transplant program performance; (3) methods used in simulated allocation models; (4) new areas of research and innovative advances in analytical methodologies that might improve the effectiveness of SRTR.
|
|
Secretary's Advisory Committee on Human Research Protections
|
Committee, Work group, Advisory group, or Task Force
|
OASH, AHRQ, CDC, FDA, HRSA, IHS, OCR, ONC
|
OD/OSP
|
The Secretary’s Advisory Committee on Human Research Protections (SACHRP) provides expert advice and recommendations to the Secretary of HHS on issues pertaining to the protection of human subjects in research.
|
|
Secretary's Advisory Committee on Infant Mortality
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD
|
The Secretary’s Advisory Committee on Infant Mortality (SACIM) was formed in 1991 to advise the Secretary on Department of Health and Human Services’ programs that are directed at reducing infant mortality and improving the health status of pregnant women and infants. https://www.hrsa.gov/advisory-committees/infant-mortality/index.html
|
|
Secretary's Tribal Advisory Committee (STAC)
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
OD/IMOD
|
The Secretary’s Tribal Advisory Committee signals a new level of attention to Government-to-Government relationship between HHS and Indian Tribal Governments.The STAC’s primary purpose is to seek consensus, exchange views, share information, provide advice and/or recommendations; or facilitate any other interaction related to intergovernmental responsibilities or administration of HHS programs, including those that arise explicitly or implicitly under statute, regulation or Executive Order. This purpose will be accomplished through forums, meetings and conversations between Federal officials and elected Tribal leaders in their official capacity (or their designated employees or national associations with authority to act on their behalf).
|
|
Secretary’s Initiative on Protecting Farmworkers from Extreme Heat and Wildfire Smoke
|
Other
|
CDC, HRSA, SAMHSA
|
NIEHS, NIMHD, NINR
|
Proposed by the HHS Secretary. It intends to facilitate communication and collaboration across HHS agencies on research, policy, and healthcare services to protect farmworkers from extreme heat and wildfire smoke (the latter related to more recent climate events in various states.
|
|
Sepsis Interagency Meeting
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, BARDA, CDC, CMS
|
NHLBI, NIAID, NICHD, NIGMS
|
Discuss Sepsis Priority Areas identified in Biomedical Advanced Research and Development (BARDA) market research: Unifying definitions of Sepsis across the patient continuum, Harmonizing Data for Access and Interoperability, Optimizing Health Outcomes and Reducing Economic Burden, Improving Evaluation and Catalyzing Adoption of Critical Technologies.
|
|
Sequencing for Public Health Emergency Response, Epidemiology and Surveillance
|
Other
|
CDC
|
NIA, NIAID, NLM
|
To help accelerate the use of near-real-time pathogen genomic data throughout the SARS-CoV-2 pandemic response and for future public health events, CDC established an open genomics consortium to spearhead and organize public health sequencing and response efforts across the United States. This consortium, Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES), helps to coordinate and support sequencing at state and local public health laboratories, and to better engage clinical, academic and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 at any scale. The consortium aims to: improve communication and knowledge-sharing between U.S. laboratories; develop consensus guidance on data and metadata standards; reduce barriers to bioinformatic analysis and data sharing; and better align sequencing requirements and resource needs with different sources of funding, technology, expertise, and other means of support. https://www.cdc.gov/advanced-molecular-detection/php/spheres/
|
|
Sequencing Quality Control Phase 2 (SEQC2)
|
Resource Development
|
OS, FDA
|
CIT, NCI, NHLBI, NIEHS, NLM
|
The Sequencing Quality Control (SEQC) consortium is an FDA-led community-wide effort. SEQC Phase 2 (SEQC2) is a project within the consortium. The goals of SEQC2 are to: (1) develop quality metrics for reproducible next-generation sequencing (NGS) results from both whole genome sequencing (WGS) and targeted gene sequencing (TGS); (2) benchmark bioinformatics methods for WGS and TGS towards the development of standard data analysis protocols; and (3) assess the joint effects of key parameters affecting NGS results and interpretation for clinical application. NLM/NCBI provides an NCBI data portal and contributes data analysis to this effort.
|
|
Serum organochlorine/PCB concentrations and risk of prostate cancer in men from Ghana
|
Research Initiative
|
CDC
|
NCI
|
National Cancer Institute (NCI) and Centers for Disease Control and Prevention (CDC) are collaborating to measure serum levels of persistent organic pollutants for a case-control study of prostate cancer in the Ghana Prostate Study.
|